Mdvip
Personalized care
Based in FL
🤖
AI Overview
With $1.4M in lobbying spend across 29 quarterly filings, Mdvip is a significant lobbying presence. They deploy 31 individual lobbyists
$1.4M
Total Lobbying Spend
29
Quarterly Filings
1
Lobbying Firms Used
31
Individual Lobbyists
Spending by Year
| Year | Lobbying Spend |
|---|---|
| 2018 | $250K |
| 2019 | $150K |
| 2020 | $150K |
| 2021 | $150K |
| 2022 | $200K |
| 2023 | $200K |
| 2024 | $180K |
| 2025 | $90K |
Lobbying Firms
MEHLMAN CONSULTING, INC.
What They Lobby For
- Graham-Cassidy Amendment; Bi-partisan Healthcare Stabilization Act of 2017 (Alexander-Murray). Implementation of PL 115-97 (H.R. 1/tax reform).
- Direct and Primary Care. Graham-Cassidy Amendment; Bi-partisan Healthcare Stabilization Act of 2017 (Alexander-Murray).
- Graham-Cassidy Amendment; Bi-partisan Healthcare Stabilization Act of 2017 (Alexander-Murray).
- Direct and Primary Care.
- Implementation of PL 115-97 (H.R. 1/tax reform). H.R. 6199 - Restoring Access to Medication and Modernizing Health Savings Accounts Act of 2018. H.R. 6311 - Increasing Access to Lower Premium Plans and Expanding Health Savings Accounts Act of 2018.
- Healthcare Quality; Primary Care
- Access to primary care physicians; medicare reimbursement.
- Health savings account coverage for primary care.
- Health savings account coverage for primary care. H.R.2177 - Faith in Health Savings Accounts Act of 2019. S.12 - Health Savings Act of 2019. H.R.603 - Health Savings Account Expansion Act of 2019. H.R.457 - Health Savings Account Act. H.R. 3708 - Primary Care Enhancement Act of 2019.
- Access to primary care physicians; Medicare reimbursement.
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.